Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
art, average, BICR, blinded, camsylate, central, CHMP, cleared, composition, constellation, counterpart, Department, dosage, dosing, endpoint, extension, favorable, forthcoming, found, Grossmann, high, imposition, independent, inventive, joint, Justice, key, lack, likewise, LLP, modification, novelty, overcompensated, PFS, placebo, platinum, polymorph, polymorphic, preliminarily, protection, repleading, resolve, Restoration, salt, sNDA, Solak, strength, supplementary, survival, unexpected, Verified, weighted, wrongful
Filing tables
Filing exhibits
Related press release
CLVSQ similar filings
Filing view
External links
|
|
|
|
| Exhibit 21.1 |
List of Subsidiaries of Clovis Oncology, Inc. | ||
|
|
|
Name: |
| Jurisdiction of Organization: |
Clovis Oncology UK Limited |
| United Kingdom |
Clovis Oncology Italy Srl |
| Italy |
Clovis Oncology IT Srl |
| Italy |
Clovis Oncology Switzerland GmbH |
| Switzerland |
Clovis Oncology France SAS |
| France |
Clovis Oncology Spain SL |
| Spain |
Clovis Oncology Germany GmbH |
| Germany |
Clovis Oncology Denmark ApS |
| Denmark |